Skip to main content

Home/ Cancer/ Group items tagged prostate

Rss Feed Group items tagged

Matti Narkia

ScienceDaily: Vitamin D Inhibits Progression Of Some Prostate Cancers - 0 views

  •  
    ScienceDaily (Feb. 8, 2006) - Vitamin D can inhibit the spread of prostate cancer cells by limiting the activity of two specific enzymes, University of Rochester Medical Center scientists report. \n\nThe finding means that vitamin D could provide beneficial treatment to prostate cancer patients with high levels of the enzymes, the scientists said.\n
Matti Narkia

Vitamin K2 Linked to Lower Prostate Cancer Risk - Drugs.com MedNews - 0 views

  •  
    LYSAKER, Norway, April 11, 2008-An increased intake of vitamin K2 may reduce the risk of prostate cancer by 35 per cent, suggest results from the European Prospective Investigation into Cancer and Nutrition (EPIC). The findings, based on dietary intake from 11,319 men taking part in the EPIC Heidelberg cohort, are published in this month's issue of the American Journal of Clinical Nutrition.
Matti Narkia

ScienceDaily: Vitamin D, NSAIDS Provide Double Whammy Against Prostate Cancer, Stanford... - 0 views

  •  
    ScienceDaily (Sep. 1, 2005) - STANFORD, Calif. - The growth of prostate cancer cells can be halted by combining a form of vitamin D, available only by prescription, with low doses of an over-the-counter painkiller, researchers at the Stanford University School of Medicine have found. The combination reduced prostate cancer cell growth in a laboratory dish by up to 70 percent, according to the findings, published in the Sept. 1 issue of Cancer Research.
Matti Narkia

Prostate Cancer, Prostate Cancer Symptoms, Prostrate Cancer - Prostate Cancer Foundation - 0 views

  •  
    Prostate Cancer Foundation
Matti Narkia

Prostate Forum - 0 views

  •  
    Whether you're deciding on brachytherapy or are interested in nutraceuticals and diet, Prostate Forum tackles the latest on prostate cancer and beyond, responding with timely information for men of any age or at any stage of treatment.\n\nDr. Myers answer
paijo9

Prostate Cancer Facts   - 0 views

  •  
    One prostate problem does not lead to another. For example, having prostatitis or an enlarged prostate does not increase the chance for prostate cancer.
Matti Narkia

Mayo researchers: Dramatic outcomes in prostate cancer study - 0 views

  •  
    ROCHESTER, Minn. -- Two Mayo Clinic patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental drug therapy that was used in combination with standardized hormone treatment and radiation therapy. The men were participating in a clinical trial of an immunotherapeutic agent called MDX-010 or ipilimumab. In these two cases, physicians say the approach initiated the death of a majority of cancer cells and caused the tumors to shrink dramatically, allowing surgery. In both cases, the aggressive tumors had grown well beyond the prostate into the
Matti Narkia

Association between serum 25(OH)D and death from prostate cancer - British Journal of C... - 0 views

  •  
    Association between serum 25(OH)D and death from prostate cancer. Tretli S, Hernes E, Berg JP, Hestvik UE, Robsahm TE. Br J Cancer. 2009 Feb 10;100(3):450-4. Epub 2009 Jan 20. PMID: 19156140 doi:10.1038/sj.bjc.6604865 The serum level of 25(OH)D may be involved in disease progression and is a potential marker of prognosis in patients with prostate cancer.
Matti Narkia

Folic Acid Supplements Linked To Higher Risk Of Prostate Cancer, Study Shows - 0 views

  •  
    ScienceDaily (Mar. 10, 2009) - A study led by researchers at the University of Southern California (USC) found that men who took a daily folic acid supplement of 1 mg daily had more than twice the risk of prostate cancer compared with men who took a placebo.
Matti Narkia

MedWire News - Prostate Cancer - No link between steroid hormones and prostate cancer G... - 0 views

  • “Whether this discrepancy was simply a results of different populations of men in these studies or, more likely, the absence of a consistent biologic relationship, our results suggest that steroid hormones are not a powerful driver of higher grade disease.”
  •  
    MedWire News: Among patients with newly diagnosed prostate cancer, there is no link between circulating steroid hormone levels and Gleason score, conclude US investigators.
Matti Narkia

Vitamin D boosts NSAID cancer-fighting power - 0 views

  •  
    Low doses of the active form of vitamin D and non-steroidal anti-inflammatory drugs act as a powerful combination to halt the growth of prostate cancer cells, say US scientists. Writing in Cancer Research, a team from Stanford University says it discovered that the amount of both activated vitamin D, or calcitriol, and NSAIDs could be reduced by half to one-tenth the dosage to thwart prostate cancer cell growth in cell lines and primary tissue culture
Matti Narkia

Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the... - 0 views

  •  
    Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg).\nNimptsch K, Rohrmann S, Linseisen J.\nAm J Clin Nutr. 2008 Apr;87(4):985-92.\nPMID: 18400723
Matti Narkia

Advanced Prostate Cancer - Sharing experiences, support and advise for men with advance... - 0 views

  •  
    Sharing experiences, support and advise for men with advanced & recurrent Prostate Cancer
Matti Narkia

Dietary Omega-3 Fatty Acids, Cyclooxygenase-2 Genetic Variation, and Aggressive Prostat... - 0 views

  •  
    Dietary Omega-3 Fatty Acids, Cyclooxygenase-2 Genetic Variation, and Aggressive Prostate Cancer Risk. Fradet V, Cheng I, Casey G, Witte JS. Clin Cancer Res. 2009 Mar 24. [Epub ahead of print] PMID: 19318492 DOI: 10.1158/1078-0432.CCR-08-2503
medicoexperts

Laser treatment for prostate cancer | MedicoExperts - 0 views

  •  
    Newer and innovative medical technologies like laser ablations have proven safe and effective in treating patients with prostate cancer in India.
Matti Narkia

Apoptotic effects of dietary and synthetic sphingolipids in androgen-independent (PC-3)... - 0 views

  •  
    Apoptotic effects of dietary and synthetic sphingolipids in androgen-independent (PC-3) prostate cancer cells. Kent KD, Clubbs EA, Harper WJ, Bomser JA. Lipids. 2008 Feb;43(2):143-9. Epub 2008 Jan 10. PMID: 18188632 DOI: 10.1007/s11745-007-3148-
Matti Narkia

Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC)... - 0 views

  •  
    Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate. Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G. Eur Urol. 2005 Apr;47(4):449-54; discussion 454-5. Epub 2005 Jan 19. PMID: 15774240 doi:10.1016/j.eururo.2004.12.001
Matti Narkia

Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in h... - 0 views

  •  
    Flaig TW, Su LJ, Harrison G, Agarwal R, Glode LM. Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells. Int J Cancer. 2007 Jan 17; [Epub ahead of print] PMID: 17230508 [PubMed - as supplied
Matti Narkia

A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. -... - 0 views

  •  
    Flaig TW, Gustafson DL, Su LJ, Zirrolli JA, Crighton F, Harrison GS, Pierson AS, Agarwal R, Glode LM. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Invest New Drugs. 2007 Apr;25(2):139-46. Epub 2006 Nov 1. PMID
Matti Narkia

Prostate cancer chemoprevention by silibinin: bench to bedside. - Entrez PubMed - 0 views

  •  
    Singh RP, Agarwal R. Prostate cancer chemoprevention by silibinin: bench to bedside. Mol Carcinog. 2006 Jun;45(6):436-42. Review. PMID: 16637061 [PubMed - indexed for MEDLINE]
‹ Previous 21 - 40 of 103 Next › Last »
Showing 20 items per page